186 related articles for article (PubMed ID: 29188211)
1. Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases.
Bae JW; Hong EK; Gwak HS
Brain Tumor Res Treat; 2017 Oct; 5(2):99-104. PubMed ID: 29188211
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report.
Okita Y; Nonaka M; Umehara T; Kanemura Y; Kodama Y; Mano M; Nakajima S
Oncol Lett; 2015 Apr; 9(4):1885-1888. PubMed ID: 25789061
[TBL] [Abstract][Full Text] [Related]
3. The clinical features of spinal leptomeningeal dissemination from malignant gliomas.
Bae JS; Yang SH; Yoon WS; Kang SG; Hong YK; Jeun SS
J Korean Neurosurg Soc; 2011 Jun; 49(6):334-8. PubMed ID: 21887390
[TBL] [Abstract][Full Text] [Related]
4. Cyberknife Radiosurgery and Concurrent Intrathecal Chemotherapy for Leptomeningeal Metastases: Case Report of Prolonged Survival of a HER-2+ Breast Cancer Patient Status-Post Craniospinal Irradiation.
Lekovic G; Drazin D; Mak AC; Schwartz MS
Cureus; 2016 Jan; 8(1):e453. PubMed ID: 26918221
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis.
Kang X; Chen F; Yang SB; Wang YL; Qian ZH; Li Y; Lin H; Li P; Peng YC; Wang XM; Li WB
World J Clin Cases; 2022 Jun; 10(17):5595-5605. PubMed ID: 35979103
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
8. Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide.
Michotte A; Chaskis C; Sadones J; Veld PI; Neyns B
J Neurol Sci; 2009 Dec; 287(1-2):267-70. PubMed ID: 19751941
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination.
Mazloom A; Hodges JC; Teh BS; Chintagumpala M; Paulino AC
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):350-4. PubMed ID: 22401918
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis.
Roldán G; Scott J; George D; Parney I; Easaw J; Cairncross G; Forsyth P; Yan E
Can J Neurol Sci; 2008 May; 35(2):204-9. PubMed ID: 18574935
[TBL] [Abstract][Full Text] [Related]
11. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.
Piña Y; Yadugiri S; Yeboa DN; Ferguson SD; Forsyth PA; Oliva ICG
Curr Oncol Rep; 2022 Jan; 24(1):43-54. PubMed ID: 35059999
[TBL] [Abstract][Full Text] [Related]
12. Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon.
Perilongo G; Garrè ML; Giangaspero F
Childs Nerv Syst; 2003 Apr; 19(4):197-203. PubMed ID: 12682758
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials.
Palmisciano P; Watanabe G; Conching A; Ogasawara C; Vojnic M; D'Amico RS
J Neurooncol; 2022 Oct; 160(1):79-100. PubMed ID: 35999434
[TBL] [Abstract][Full Text] [Related]
14. Fatal hemorrhage after radiochemotherapy for leptomeningeal dissemination of glioma: report of two cases.
Saito R; Kumabe T; Jokura H; Yoshimoto T
Surg Neurol; 2002 Jan; 57(1):46-8. PubMed ID: 11834277
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials.
Buszek SM; Chung C
Front Oncol; 2019; 9():1224. PubMed ID: 31803614
[No Abstract] [Full Text] [Related]
16. Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis.
Witham TF; Fukui MB; Meltzer CC; Burns R; Kondziolka D; Bozik ME
Cancer; 1999 Oct; 86(7):1347-53. PubMed ID: 10506724
[TBL] [Abstract][Full Text] [Related]
17. Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children.
Grabb PA; Albright AL; Pang D
Neurosurgery; 1992 Jan; 30(1):64-71. PubMed ID: 1738457
[TBL] [Abstract][Full Text] [Related]
18. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.
Mandel JJ; Yust-Katz S; Cachia D; Wu J; Liu D; de Groot JF; Yung AW; Gilbert MR
J Neurooncol; 2014 Dec; 120(3):597-605. PubMed ID: 25168214
[TBL] [Abstract][Full Text] [Related]
19. Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma.
Yang P; Zhang C; Cai J; You G; Wang Y; Qiu X; Li S; Wu C; Yao K; Li W; Peng X; Zhang W; Jiang T
Oncotarget; 2016 Nov; 7(48):80091-80100. PubMed ID: 27590514
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma.
Fujimaki T; Ishii H; Matsuno A; Arai H; Nakagomi T
World J Surg Oncol; 2007 Aug; 5():89. PubMed ID: 17683572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
